News and Comments


  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...


  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...

Recent Postings



Valeant Pharmaceuticals International (VRX) Alder Biopharmaceuticals (ALDR) ZALTRAP™ Endometrial Cancer Micromet (MITI) Regeneron (REGN) Vertex (VRTX) TOKAI (TKAOI) Merck (MRK) Pluristem (PSTI) Onyx (ONXX) Roche (RHHBY) Incyte (INCY) Intercept (ICPT) NEKTAR (NKTR)) Sanofi-Aventis (SAN) SUNESIS PHARMACEUTICALS (SNSS) Galena (GALE) RenenxBio (RGNX) KITE (KITE) Exelixis (EXEL) ImmunoGen (IMGN) Intermune (ITMN) GUARDIAN HEALTH Illumina (ILMN) ADVENTRIX (ANX) Ridaforolimus Anacor (ANAC) SERES THERAPEUTICS (MCRB) INNOVIVA (INVA) Bellicum (BLCM) Gilead (GILD) AGOS (ARGS) ISIS (ISIS) CompuGen (CGEN) Intrexon (XON) Prosensa (RNA) Zerenex BIOMARIN (BMRN) Xoma (XOMA) Theravance (THRX) Alnylam (ALNY) Abbott Laboratories (ABT) Rapamune C4 Therapeutics GlaxoSmithKline (GSK) ARCA (ABIO) Biocryst (BCRX) VANDA (VNDA) Human Longevity (HLI) Telaprevir Advaxis (ADXS) Sangamo (SGMO) KERYX (KERX) Sarepta (SRPT) ACADIA (ACAD) Agenus (AGEN) PTC Therapeutics (PTCT) Auspex (ASPX) Mirati Therapeutics (MRTX) MODERNA Jazz Pharmaceuticals (JAZZ) Cytokinetics (CYTK) Elan (ELN) ABBVIE (ABBV) Sanofi (SNA) Prolor Biotech (PBTH) CRISPR Therapeutics (CRSP) HALOZYME (HALO) Seattle Genetics (SGEN) AERIE PHARMACEUTICALS Ziofpharm (ZIOP) Ariad (ARIA) Ocular Therapeutix (OCUL) Human Genome Sciences (HGSI) Revlimid (lenolidamide) Benlysta (belimumab) Array Pharmaceuticals (ARRY) Dynavax (DVAX) Aimmune Therapeutics (AIMT) SYNTA (SNTA) Inovio (INO) Anadys (ANDS) Biogen Idec (BIIB) AstraZeneca (AZN) NANTKWEST (NK) ARGOS (ARGS) REGULUS (RGLS) OSI (OSIP) IDERA (IDRA) Theravance Bio Pharma (TBPH) NOVOCURE (NVCR) Dendreon (DNDN) Sequenom (SQNM) Herceptin galapagos (GLPG) Bristol-Myers Squibb (BMY) Agenus (AGEN Editas (EDIT) Spike Therapeutics (ONCE) Roche (ROCHE) Adaptimmune (ADAP) Trastuzumab-DM1 Multiple Myeloma Global Cell Therapeutics (GBT) Amgen (AMGN) Vitae Pharmaceuticals (VTAE) Sanofi (SNY) Velcade (bortezomib) Genentech JUNO (JUNO) Idenix (IDIX) Tysabri Ionis (IONS)